RUTHERFORD, N.J. — Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein. CBGMs offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback